May 11, 2021 / 06:00PM GMT
Tazeen Ahmad - BofA Securities, Research Division - VP
Hello, everybody, good afternoon. Welcome back to the Bank of America Health Care Conference. It's my pleasure to have our next presenting company with us for the next 30 minutes. We have a couple of members from the Sarepta management team with us; CEO, Doug Ingram; as well as CFO, Ian Estepan. Gentlemen, good afternoon. It's always a pleasure to host you guys, and thanks for doing us the favor of participating in our conference this year.
Douglas S. Ingram - Sarepta Therapeutics, Inc. - President, CEO & Director
Tazeen, thank you very much. We're honored to be here.
Questions and Answers:
Tazeen Ahmad - BofA Securities, Research Division - VPI don't think we need to waste time asking you to describe to everyone what Sarepta does. I think that is I think everyone is quite familiar, so maybe we can go into details if that's okay, though. Maybe talk about what you think the most important catalysts that are upcoming are for the rest of the year for the